Evaluation of the performance of the quotient MosaiQ™ COVID-19 professional use microarray assay for the detection of antibodies to SARS CoV-2 in a clinical setting

Bibliographic Details
Main Authors: José Vicario, Raquel Alenda-Asensi, Irene Lucea-Gallego, Javier Sánchez-Bonilla, Rebeca Saez, Reginald Clayton, David Robson, Janine Robb, Luisa Barea-Garcia
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Journal of Clinical Virology Plus
Online Access:http://www.sciencedirect.com/science/article/pii/S2667038021000144
_version_ 1818580925858971648
author José Vicario
Raquel Alenda-Asensi
Irene Lucea-Gallego
Javier Sánchez-Bonilla
Rebeca Saez
Reginald Clayton
David Robson
Janine Robb
Luisa Barea-Garcia
author_facet José Vicario
Raquel Alenda-Asensi
Irene Lucea-Gallego
Javier Sánchez-Bonilla
Rebeca Saez
Reginald Clayton
David Robson
Janine Robb
Luisa Barea-Garcia
author_sort José Vicario
collection DOAJ
first_indexed 2024-12-16T07:25:21Z
format Article
id doaj.art-e35cd3e98ccf48e09e19c03f73015da4
institution Directory Open Access Journal
issn 2667-0380
language English
last_indexed 2024-12-16T07:25:21Z
publishDate 2021-06-01
publisher Elsevier
record_format Article
series Journal of Clinical Virology Plus
spelling doaj.art-e35cd3e98ccf48e09e19c03f73015da42022-12-21T22:39:31ZengElsevierJournal of Clinical Virology Plus2667-03802021-06-0111100022Evaluation of the performance of the quotient MosaiQ™ COVID-19 professional use microarray assay for the detection of antibodies to SARS CoV-2 in a clinical settingJosé Vicario0Raquel Alenda-Asensi1Irene Lucea-Gallego2Javier Sánchez-Bonilla3Rebeca Saez4Reginald Clayton5David Robson6Janine Robb7Luisa Barea-Garcia8Immunology, Centro de Transfusión de Madrid, Av de la Democracia s/n, 28032, Madrid, SpainImmunology, Centro de Transfusión de Madrid, Av de la Democracia s/n, 28032, Madrid, SpainBlood donor laboratory, Centro de Transfusión de Madrid, Av de la Democracia s/n, 28032, Madrid, SpainCommercial and Strategy, Quotient, Business Park Terre Bonne, Route de Crassier 13, 1262, Eysins, SwitzerlandCommercial and Strategy, Quotient, Business Park Terre Bonne, Route de Crassier 13, 1262, Eysins, SwitzerlandResearch and Development, Quotient, Allan-Robb Campus, 5 James Hamilton Way, Milton Bridge, Penicuik, EH26 0BF, United KingdomResearch and Development, Quotient, Allan-Robb Campus, 5 James Hamilton Way, Milton Bridge, Penicuik, EH26 0BF, United KingdomCommercial and Strategy, Quotient, Allan-Robb Campus, 5 James Hamilton Way, Milton Bridge, Penicuik, EH26 0BF, United Kingdom; Corresponding author.Management, Centro de Transfusión de Madrid, Av de la Democracia s/n, 28032, Madrid, Spainhttp://www.sciencedirect.com/science/article/pii/S2667038021000144
spellingShingle José Vicario
Raquel Alenda-Asensi
Irene Lucea-Gallego
Javier Sánchez-Bonilla
Rebeca Saez
Reginald Clayton
David Robson
Janine Robb
Luisa Barea-Garcia
Evaluation of the performance of the quotient MosaiQ™ COVID-19 professional use microarray assay for the detection of antibodies to SARS CoV-2 in a clinical setting
Journal of Clinical Virology Plus
title Evaluation of the performance of the quotient MosaiQ™ COVID-19 professional use microarray assay for the detection of antibodies to SARS CoV-2 in a clinical setting
title_full Evaluation of the performance of the quotient MosaiQ™ COVID-19 professional use microarray assay for the detection of antibodies to SARS CoV-2 in a clinical setting
title_fullStr Evaluation of the performance of the quotient MosaiQ™ COVID-19 professional use microarray assay for the detection of antibodies to SARS CoV-2 in a clinical setting
title_full_unstemmed Evaluation of the performance of the quotient MosaiQ™ COVID-19 professional use microarray assay for the detection of antibodies to SARS CoV-2 in a clinical setting
title_short Evaluation of the performance of the quotient MosaiQ™ COVID-19 professional use microarray assay for the detection of antibodies to SARS CoV-2 in a clinical setting
title_sort evaluation of the performance of the quotient mosaiq™ covid 19 professional use microarray assay for the detection of antibodies to sars cov 2 in a clinical setting
url http://www.sciencedirect.com/science/article/pii/S2667038021000144
work_keys_str_mv AT josevicario evaluationoftheperformanceofthequotientmosaiqcovid19professionalusemicroarrayassayforthedetectionofantibodiestosarscov2inaclinicalsetting
AT raquelalendaasensi evaluationoftheperformanceofthequotientmosaiqcovid19professionalusemicroarrayassayforthedetectionofantibodiestosarscov2inaclinicalsetting
AT ireneluceagallego evaluationoftheperformanceofthequotientmosaiqcovid19professionalusemicroarrayassayforthedetectionofantibodiestosarscov2inaclinicalsetting
AT javiersanchezbonilla evaluationoftheperformanceofthequotientmosaiqcovid19professionalusemicroarrayassayforthedetectionofantibodiestosarscov2inaclinicalsetting
AT rebecasaez evaluationoftheperformanceofthequotientmosaiqcovid19professionalusemicroarrayassayforthedetectionofantibodiestosarscov2inaclinicalsetting
AT reginaldclayton evaluationoftheperformanceofthequotientmosaiqcovid19professionalusemicroarrayassayforthedetectionofantibodiestosarscov2inaclinicalsetting
AT davidrobson evaluationoftheperformanceofthequotientmosaiqcovid19professionalusemicroarrayassayforthedetectionofantibodiestosarscov2inaclinicalsetting
AT janinerobb evaluationoftheperformanceofthequotientmosaiqcovid19professionalusemicroarrayassayforthedetectionofantibodiestosarscov2inaclinicalsetting
AT luisabareagarcia evaluationoftheperformanceofthequotientmosaiqcovid19professionalusemicroarrayassayforthedetectionofantibodiestosarscov2inaclinicalsetting